Shared Gene Expression Between Multiple Sclerosis and Ischemic Stroke
- PMID: 30809253
- PMCID: PMC6379658
- DOI: 10.3389/fgene.2018.00598
Shared Gene Expression Between Multiple Sclerosis and Ischemic Stroke
Abstract
Patients with multiple sclerosis (MS) appear to have an increased risk of ischemic stroke (IS). Although MS and IS have very different phenotypes, gene-based and pathway-based analyses of large-scale genome-wide association studies (GWAS) have increasingly enhanced our understanding of these two diseases. Whether there are common molecular mechanisms connecting MS and IS is still unclear. Here, we describe the outcome of gene-based test and pathway-based analysis of GWAS datasets that explored potential gene expression links between MS and IS. After identifying significant gene sets individually of MS and IS, we performed pathway-based analysis in four biological pathway databases (KEGG, PANTHER, REACTOME, and WikiPathways) and GO categories. We discovered that there were 9 shared pathways between MS and IS in KEGG, 2 in PANTHER, 14 in REACTOME, 1 in WikiPathways, and 194 in GO annotations (p < 0.05). These results provide an improved understanding about possible shared mechanisms and treatments strategies for MS and IS. They also provide some basis for further studies of how these two diseases are linked at the molecular level.
Keywords: gene-based test; genome-wide association studies; histocompatibility complex variants; ischemic stroke; multiple sclerosis; pathway-based analysis; single nucleotide polymorphism.
Figures



Similar articles
-
Shared Biological Pathways Between Alzheimer's Disease and Ischemic Stroke.Front Neurosci. 2018 Sep 7;12:605. doi: 10.3389/fnins.2018.00605. eCollection 2018. Front Neurosci. 2018. PMID: 30245614 Free PMC article.
-
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.Mult Scler. 2017 Feb;23(2):205-212. doi: 10.1177/1352458516649038. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27207450
-
Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke.Front Genet. 2020 Jul 3;11:646. doi: 10.3389/fgene.2020.00646. eCollection 2020. Front Genet. 2020. PMID: 32719717 Free PMC article.
-
Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.Mol Aspects Med. 2015 Jun-Oct;43-44:66-76. doi: 10.1016/j.mam.2015.06.006. Epub 2015 Jun 23. Mol Aspects Med. 2015. PMID: 26116273 Free PMC article. Review.
-
Genetic determinants of risk and progression in multiple sclerosis.Clin Chim Acta. 2015 Sep 20;449:16-22. doi: 10.1016/j.cca.2015.01.034. Epub 2015 Feb 4. Clin Chim Acta. 2015. PMID: 25661088 Free PMC article. Review.
Cited by
-
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.Cell Immunol. 2020 Dec;358:104219. doi: 10.1016/j.cellimm.2020.104219. Epub 2020 Sep 20. Cell Immunol. 2020. PMID: 33039896 Free PMC article. Review.
-
Platelet depletion does not alter long-term functional outcome after cerebral ischaemia in mice.Brain Behav Immun Health. 2022 Jul 21;24:100493. doi: 10.1016/j.bbih.2022.100493. eCollection 2022 Oct. Brain Behav Immun Health. 2022. PMID: 35928516 Free PMC article.
-
The Diagnostic and Prognostic Value of the Immune Checkpoint BGN in Thymoma.Biochem Genet. 2024 Jun;62(3):1872-1894. doi: 10.1007/s10528-023-10523-5. Epub 2023 Sep 30. Biochem Genet. 2024. PMID: 37776467
-
Thinking outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke.J Clin Med. 2021 Feb 7;10(4):630. doi: 10.3390/jcm10040630. J Clin Med. 2021. PMID: 33562264 Free PMC article. Review.
-
Genetic and Expression Analysis of COPI Genes and Alzheimer's Disease Susceptibility.Front Genet. 2019 Sep 19;10:866. doi: 10.3389/fgene.2019.00866. eCollection 2019. Front Genet. 2019. PMID: 31608112 Free PMC article.
References
-
- Bielekova B., Catalfamo M., Reichert-Scrivner S., Packer A., Cerna M., Waldmann T. A., et al. . (2006). Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103, 5941–5946. 10.1073/pnas.0601335103 - DOI - PMC - PubMed
-
- Brea D., Sobrino T., Rodriguez-Yanez M., Ramos-Cabrer P., Agulla J., Rodriguez-Gonzalez R., et al. . (2011). Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin. Immunol. 139, 193–198. 10.1016/j.clim.2011.02.001 - DOI - PubMed
LinkOut - more resources
Full Text Sources